Variant Subpopulations in Nitroimidazole Resistance Genes in DELIBERATE trial participants
Naufal, F.; Folkerts, M. L.; Limberis, J. D.; Streicher, E. M.; Nalyvayko, A.; Maartens, G.; Dooley, K. E.; Warren, R.; Engelthaler, D. M.; Metcalfe, J. Z.
Show abstract
Targeted next-generation sequencing (tNGS) enables rapid detection of drug resistance in Mycobacteriumtuberculosis (Mtb), including minor variants that may indicate emerging resistance. We applied tNGS to isolates from 34 (of 49 eligible) participants in a randomized trial of bedaquiline (BDQ) and delamanid (DLM) co-administration for multidrug-resistant TB (MDR-TB). We detected baseline nonsynonymous variants in the nitroimidazole resistance genes fgd2 and ddn (BDQ arm) and fbiB (DLM arm) among 2/12 and 2/12 patients, respectively, and emergent subpopulations with nonsynonymous variants in fbiB, fbiC, and ddn as early as week 1 in 3/34 patients. These findings demonstrate that variants in nitroimidazole resistance genes may be present in the absence of drug exposure, and that tNGS can effectively track variant emergence during MDR-TB treatment.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Mortality of Drug-resistant Tuberculosis in High-burden Countries: Comparison of Routine Drug Susceptibility Testing with Whole-genome Sequencing 93%
- Deciphering Bedaquiline and Clofazimine Resistance in Tuberculosis: An Evolutionary Medicine Approach 92%
- Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation 91%
Similar papers in this journal
- Exhaled Mycobacterium tuberculosis predicts incident infection in household contacts 94%
- Comparative effectiveness of three linezolid management strategies for peripheral neuropathy during multidrug- or rifampicin-resistant tuberculosis treatment 92%
- New manual qPCR assay validated on tongue swabs collected and processed in Uganda shows sensitivity that rivals sputum-based molecular TB diagnostics 91%
Similar papers in this journal
- Programmatic diagnostic accuracy and clinical utility of Xpert MTB/XDR in patients with rifampicin-resistant tuberculosis in Georgia 95%
- Potential Utility of C-reactive Protein for Tuberculosis Risk Stratification among Patients with Non-Meningitic Symptoms at HIV Diagnosis in Low- and Middle-Income Countries 93%
- C-reactive protein for pulmonary tuberculosis screening and treatment response monitoring in children 91%
Similar papers in this journal
- Genomic Sequencing from Sputum for Tuberculosis Disease Diagnosis, Lineage Determination and Drug Susceptibility Prediction 94%
- How well do routine molecular diagnostics detect rifampicin heteroresistance in Mycobacterium tuberculosis? 93%
- Predicting Isoniazid Resistance in Mycobacterium tuberculosis Complex in New York State using Whole Genome Sequencing 93%
Similar papers in this journal
- Prediction models for adverse drug reactions during tuberculosis treatment in Brazil 93%
- Efficacies of sequenced monotherapies of Mycobacterium avium lung infection in mouse 92%
- Emergence and Rising Prevalence of Artemisinin Partial Resistance Marker Kelch13 P441L in a Low Malaria Transmission Setting in Southern Zambia 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.